Lloyd Mitchell Segal - Jan 21, 2022 Form 4/A - Amendment Insider Report for Repare Therapeutics Inc. (RPTX)

Role
President and CEO, Director
Signature
/s/ Steve Forte, Attorney-in-Fact
Stock symbol
RPTX
Transactions as of
Jan 21, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
1/24/2022, 03:55 PM
Date Of Original Report
Jan 20, 2022
Previous filing
Jan 20, 2022
Next filing
Feb 1, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RPTX Employee Stock Option (right to buy) Options Exercise $0 +300K $0.00 300K Jan 21, 2022 Common Shares 300K $15.63 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 amendment is being filed to correct the original Form 4 filed on January 20, 2022. The original Form 4 was filed early with an incorrect Transaction Date due to a clerical error.
F2 Twenty-five percent (25%) of the shares subject to the option shall vest on January 18, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.